Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
17
|
| pubmed:dateCreated |
1991-8-20
|
| pubmed:abstractText |
The pulmonary hypertension (PAH) in chronic obstructive lung disease include therapy of the respiratory disease i.e. bronchodilator, kinesitherapy. Long-term oxygen therapy (more than 15 h/day) reverse the course of PAH and increase survey. Long-term efficiency of vasodilators is not well demonstrated. Primary PAH could benefit from vasodilators, especially waiting lung or heart-lung transplantation. Patients with PAH secondary to respiratory insufficiency could also be successfully transplanted. In post embolic PAH, antithrombotic agents are useful. Thrombectomy or transplantation are sometimes proposed.
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
F
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0035-2640
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
11
|
| pubmed:volume |
41
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1573-6
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading | |
| pubmed:year |
1991
|
| pubmed:articleTitle |
[Treatment of pulmonary artery hypertensions].
|
| pubmed:affiliation |
Service de pneumologie CHU Nord, Marseille.
|
| pubmed:publicationType |
Journal Article,
English Abstract
|